Christine Kilcline, MD
Procedural Dermatology · San Luis Obispo, CANPI 1093724791
Payments from drug & device makers
Across 371 payments — averaging $49.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$6K
- Sanofi$3K
- AbbVie$2K
- Lilly USA, LLC$744
- Merz North America, Inc.$743
- Novartis$723
- plus $5K from 25 others
What the payments were for
- Consulting fees$2,10611%
- Speaking & faculty fees$5,84032%
- Travel & lodging$160%
- Food & beverage$10,21956%
- Education$1901%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 16 | $6,025 |
| Sanofi | 8 | $2,593 |
| AbbVie(2 entities) | 81 | $2,106 |
| Lilly USA, LLC | 31 | $744 |
| Merz North America, Inc. | 15 | $743 |
| Novartis | 39 | $723 |
| UCB, Inc. | 15 | $634 |
| Pfizer | 20 | $546 |
| E.r. Squibb & Sons, L.L.C. | 11 | $539 |
| Regeneron Healthcare Solutions, Inc. | 16 | $512 |
| Johnson & Johnson | 17 | $459 |
| Organogenesis Inc. | 5 | $433 |
| Galderma Laboratories, L.p. | 16 | $399 |
| Revance Therapeutics, Inc. | 9 | $290 |
| Sun Pharmaceutical Industries Inc. | 13 | $277 |
| Arcutis Biotherapeutics, Inc. | 11 | $263 |
| Biofrontera Inc. | 9 | $184 |
| LEO Pharma Inc. | 7 | $135 |
| Sanofi-aventis U.S. LLC | 2 | $124 |
| Amgen | 5 | $120 |
| Organon | 5 | $97 |
| Boehringer Ingelheim | 2 | $62 |
| Pierre Fabre Pharmaceuticals, Inc. | 2 | $54 |
| Journey Medical Corporation | 2 | $49 |
| Bristol Myers Squibb | 3 | $47 |
| VYNE Pharmaceuticals Inc. | 2 | $45 |
| DUSA Pharmaceuticals, Inc. | 2 | $39 |
| Genentech USA, Inc. | 3 | $39 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $38 |
| EPI Health, LLC | 1 | $29 |
| Dermavant Sciences, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,371 in reported general payments places this provider in the 80th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 13 | $88,188 |
| Fluorouracil | 43 | $2,765 |
| Isotretinoin | 13 | $1,394 |
| Clobetasol Propionate | 24 | $994 |
| Metronidazole | 13 | $807 |
| Triamcinolone Acetonide | 35 | $300 |
| Dutasteride | 21 | $290 |
| Ketoconazole | 14 | $199 |
| Hydrocortisone | 21 | $63 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in San Luis Obispo
- John SiebenlistSan Luis Obispo$5K
- Sabrina FabiSan Diego$6.8M
- Natasha MesinkovskaMission Viejo$4M
- Sam Khalifianla Mesa$3.6M
- Mitchel GoldmanSan Diego$1.5M
- Jeanette BlackLos Angeles$492K
- Suzanne KilmerSacramento$475K
- Rebecca FitzgeraldLos Angeles$324K
- Aram KechichianSanta Clarita$300K
- Christopher ZacharyIrvine$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.